New drug could ease withdrawal in Opioid-Exposed newborns
NCT ID NCT06047834
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study tests whether a medicine called lofexidine can safely reduce withdrawal symptoms in newborns who were exposed to opioids before birth. About 24 babies will receive either standard care alone or standard care plus lofexidine. The goal is to find the right dose and see if it helps babies feel better faster.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID WITHDRAWAL (DISORDER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Marshall Health
Huntington, West Virginia, 25701, United States
Conditions
Explore the condition pages connected to this study.